Concepedia

Maria Angelica Stamato

MA

Statistics

Publications

6

Citations

648

H-Index

6

Active since

2015

Affiliations

Magna Graecia University(Current)

Temple University

VA Boston Healthcare System

Dana-Farber Cancer Institute

University of Milan

Maria Angelica Stamato is an author at Magna Graecia University specializing in molecular oncology, multiple myeloma, and rna interference.

Publications per year

2015–2018

6

Publications

6

Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity

Nicola Amodio, Maria Angelica Stamato, Giada Juli et al. · Leukemia · 2018 · 252 citations · Full text

, , +17

A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells

Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio et al. · Clinical Cancer Research · 2015 · 120 citations · Full text

, , +17

Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma

Nicola Amodio, Maria Angelica Stamato, Annamaria Gullà et al. · Molecular Cancer Therapeutics · 2016 · 118 citations · Full text

, , +17

Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92

Eugenio Morelli, Lavinia Biamonte, Cinzia Federico et al. · Blood · 2018 · 74 citations · Full text

, , +16

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma

Maria Angelica Stamato, Giada Juli, Enrica Romeo et al. · Oncotarget · 2017 · 71 citations · Full text

, , +17

1–5 of 6